Suchergebnisse - "Padmanabhan, Srivatsan"

PubPharm (15)

1

International Pediatric COVID-19 Severity Over the Course of the Pandemic

enthalten in: JAMA pediatrics | 2023

von Zhu, Y. | Almeida, F. | Baillie, J. | +147

ErratumIn: JAMA Pediatr. 2024 Jan 1;178(1):99. - PMID 37930672

2

The Coronavirus Disease 2019 (COVID-19) Pan-Syndemic-Will We Ever Learn?

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2021

von Padmanabhan, S.

CommentOn: Clin Infect Dis. 2021 Nov 2;73(9):e2970-e2975. - PMID 33141164

3

Nitazoxanide against COVID-19 in three explorative scenarios

enthalten in: Journal of infection in developing countries | 2020

von Meneses Calderón, J. | Figueroa Flores, M. | Paniagua Coria, L. | +8

4

Treatment with Hydroxychloroquine vs Hydroxychloroquine + Nitazoxanide in COVID-19 patients with risk factors for poor prognosis : A structured summary of a study protocol for a randomised controlled trial

enthalten in: Trials | 2020

von Calderón, J. | Zerón, H. | Padmanabhan, S.

5

Treatment with Hydroxychloroquine vs Hydroxychloroquine + Nitazoxanide in COVID-19 patients with risk factors for poor prognosis: A structured summary of a study protocol for a randomised controlled trial

enthalten in: Trials | 2020

von Calderón, J. | Zerón, H. | Padmanabhan, S.

6

Treatment with Hydroxychloroquine vs Hydroxychloroquine + Nitazoxanide in COVID-19 patients with risk factors for poor prognosis: A structured summary of a study protocol for a randomised controlled trial

enthalten in: Trials | 2020

von Calderón, J. | Zerón, H. | Padmanabhan, S.

7

Genome-wide co-occupancy of AML1-ETO and N-CoR defines the t(8;21) AML signature in leukemic cells

enthalten in: BMC genomics | 2015

von Trombly, D. | Whitfield, T. | Padmanabhan, S. | +6

8

Genome-wide co-occupancy of AML1-ETO and N-CoR defines the t(8;21) AML signature in leukemic cells

enthalten in: BMC genomics | 2015

von Trombly, D. | Whitfield, T. | Padmanabhan, S. | +6

9

Genome-wide co-occupancy of AML1-ETO and N-CoR defines the t(8;21) AML signature in leukemic cells

enthalten in: BMC genomics | 2015

von Trombly, D. | Whitfield, T. | Padmanabhan, S. | +6

10

Abstract B28: Co-occupancy of AML1-ETO and N-CoR defines a dominant phenotypic signature in leukemic cells

enthalten in: Clinical cancer research | 2015

von Trombly, D. | Whitfield, T. | Padmanabhan, S. | +6